/Companies

セルスペクト株式会社

Morioka, JP · 3 known investors

Find your way into セルスペクト株式会社

Sign up to see every warm intro you have to セルスペクト株式会社

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the セルスペクト株式会社 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.

Founders & leadership

TITakuya Iwabuchi
Takuya Iwabuchi代表取締役兼CEO (Representative Director & CEO)
WH
Wataru HojoExecutive Officer & CTO

Investors · 3

Frequently asked questions

What does セルスペクト株式会社 do?
Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.
Who founded セルスペクト株式会社?
セルスペクト株式会社 was founded by Takuya Iwabuchi.
Who are セルスペクト株式会社's investors?
セルスペクト株式会社's investors include Tokyo University of Science Innovation Capital, Iwagin Business Creation Capital, Mitsubishi UFJ Capital.
Where is セルスペクト株式会社 headquartered?
セルスペクト株式会社 is headquartered in Morioka, JP.